Department of Obstetrics, Strasbourg University Hospital, Strasbourg, Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Centre for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), DHU Risks in pregnancy, Paris Descartes University, Paris, Port Royal Maternity Unit, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, DHU Risks in Pregnancy, Paris Descartes University, Paris, Louis Mourier Hospital, Department of Obstetrics and Gynecology, Assistance Publique-Hôpitaux de Paris, DHU Risks in pregnancy, Paris Diderot University, Colombes, Department of Public Health, Strasbourg University Hospital, Strasbourg, and INSERM UMR-S 1121 “Biomaterials and Bioengineering,” Strasbourg University Hospital, Strasbourg, France.
Corresponding author: Floriane Jochum, MPH, Hôpitaux Universitaires de Strasbourg, Service de Gynécologie Obstétrique, Strasbourg, France; email: [email protected].
The MEDIP study was funded by the National Agency for Drug Safety and Health Products as part of a call for research projects (No. AAP-2014-030).
Financial Disclosure The authors did not report any potential conflicts of interest.
Presented at the Society for Maternal-Fetal Medicine's annual meeting, February 11–16, 2019, Las Vegas, Nevada.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/B469.